Significance of Interleukin-6 in Papillary Thyroid Carcinoma

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/jtr/volume-2016/6178921/figures/6178921.fig.002a.svgz" name="6178921.fig.002a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>IL-6 expression in benign goiter</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/jtr/volume-2016/6178921/figures/6178921.fig.002b.svgz" name="6178921.fig.002b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>IL-6 expression in PTC</td></tr></table>

<div>Representative staining patterns of IL-6 expression in primary tumours of patients with benign thyroid diseases and PTC.</div>

Journal of Thyroid Research

fig2

Figure 2

Figure 2: Significance of Interleukin-6 in Papillary Thyroid Carcinoma 